Published in
Impact Journals, Oncotarget, 3(9), p. 4090-4101, 2017
DOI: 10.18632/oncotarget.23734
Links
Tools
The vascular disrupting agent combretastatin A-4 phosphate causes prolonged elevation of proteins involved in heme flux and function in resistant tumor cells
Journal article published in 2017 by
Sanchareeka Dey,
Sharda Kumari,
Sarada Preeta Kalainayakan,
James Campbell,
Poorva Ghosh,
Heling Zhou,
Keely E. FitzGerald,
Maoping Li,
Ralph P. Mason,
Li Zhang 
,
Li Liu
,
Li Liu
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 